【华检医疗(01931.HK)拟发行约31.42亿港元代价股份收购国富量子(00290.HK)20.31%股权 进一步完善在RWA与数字金融领域的战略布局】智通财经APP讯，华检医疗(01931.HK)公布，于2025年9月1日，该公司全资附属FinalTouchLtd.拟收购国富量子(00290.HK)合共约18.48亿股股份，约占目标公司全部已发行股本的20.31%，代价为约31.42亿港元，将由该公司根据一般授权按发行价(即每股9.69港元)配发及发行代价股份予以支付。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.